Literature DB >> 29474707

Immune Relevant Models for Ocular Inflammatory Diseases.

Brian C Gilger1.   

Abstract

Ocular inflammatory diseases, such as dry eye and uveitis, are common, painful, difficult to treat, and may result in vision loss or blindness. Ocular side effects from the use of antiinflammatory drugs (such as corticosteroids or nonsteroidal antiinflammatories) to treat ocular inflammation have prompted development of more specific and safer medications to treat inflammatory and immune-mediated diseases of the eye. To assess the efficacy and safety of these new therapeutics, appropriate immune-relevant animal models of ocular inflammation are needed. Both induced and naturally-occurring models have been described, but the most valuable for translating treatments to the human eye are the animal models of spontaneous, immunologic ocular disease, such as those with dry eye or uveitis. The purpose of this review is to describe common immune-relevant models of dry eye and uveitis with an overview of the immuno-pathogenesis of each disease and reported evaluation of models from small to large animals. We will also review a selected group of naturally-occurring large animal models, equine uveitis and canine dry eye, that have promise to translate into a better understanding and treatment of clinical immune-relevant ocular disease in man.
© The Author(s) 2018. Published by Oxford University Press on behalf of the National Academy of Sciences. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  animal models; dry eye; immune-relevant; inflammatory; naturally-occurring; ocular; uveitis

Mesh:

Year:  2018        PMID: 29474707     DOI: 10.1093/ilar/ily002

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  3 in total

Review 1.  Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye.

Authors:  Brian C Gilger; Matthew L Hirsch
Journal:  Int J Mol Sci       Date:  2022-03-23       Impact factor: 5.923

2.  Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy.

Authors:  Elizabeth Crabtree; Katy Uribe; Sara M Smith; Darby Roberts; Jacklyn H Salmon; Jacquelyn J Bower; Liujiang Song; Prabhakar Bastola; Matthew L Hirsch; Brian C Gilger
Journal:  PLoS One       Date:  2022-08-18       Impact factor: 3.752

3.  AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis.

Authors:  Elizabeth Crabtree; Liujiang Song; Telmo Llanga; Jacquelyn J Bower; Megan Cullen; Jacklyn H Salmon; Matthew L Hirsch; Brian C Gilger
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.